Design for Peptide DeliverySM

 

  • Assess drug delivery compatibility of a peptide
  • Screen peptides for drug delivery
  • Match peptide properties with proven
    drug delivery technologies
  • Launch products sooner by
    decreasing development time

 

Proven drug delivery technologies are prefered for future products because these technologies have gone through the rigors of regulatory review, manufacturing, and market acceptance. To target proven drug delivery technologies, the SurModics Pharmaceuticals - Genzyme team performs drug-delivery-based preformulation screening on lead peptides in discovery. Additionally, the SurModics Pharmaceuticals - Genzyme team optimizes candidate peptides for long-acting parenteral delivery. <Click here for more details>

 


Events

Controlled Release Society Annual Meeting
10-14 July 2010
Portland, OR
Genzyme Booth 625
SurModics Booth 521
  
European Peptide Symposium
5-9 September 2010
Copenhagen, Denmark
Genzyme Booth 19

AAPS Annual Meeting
15-17 November 2010
New Orleans, LA
Genzyme Booth 2405
SurModics Booth 909

BIO Europe
15-17 November 2010
Munich, Germany

 

News

Webinar Archive: Screening Peptides for Extended Release

 

Genzyme Pharmaceuticals and SurModics Pharmaceuticals Enter Broad Collaboration